Cost Plus Drug Company vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Mark Cuban Cost Plus Drug Company offers generic prescription medications at transparent cost-plus pricing; has expanded to over 2,500 generic drugs priced at cost plus 15% markup; partners with pharmacies nationwide;
About
Mark Cuban Cost Plus Drug Company (also known as Cost Plus Drugs) is a direct-to-consumer pharmaceutical company co-founded in 2022 by Mark Cuban and Alex Oshmyansky and headquartered in Dallas, Texas. The company disrupts the opaque and often inflated pricing of generic pharmaceuticals by operating on a transparent cost-plus model: it sources generic drugs directly from manufacturers, adds a fixed 15% markup, a $3 pharmacy labor fee, and a $5 shipping fee — publishing the final price for every drug openly on its website. This approach bypasses the traditional pharmacy benefit manager (PBM) system, which critics argue inflates drug prices through rebate structures that benefit intermediaries at the expense of patients and payers.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.